C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2001
12/12/2001	EP0981340B1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
12/12/2001	EP0767790B1 Condensed imidazole compounds, their production and use
12/12/2001	EP0663912B1 Heterocyclic ether compounds that enhance cognitive function
12/12/2001	CN1326458A CRF receptor antagonists and methods relating thereto
12/12/2001	CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors
12/12/2001	CN1325624A Herbicides of benzoyloxy unsaturated carboxylate type
12/11/2001	US6329394 Medical use for tachykinin antagonists
12/11/2001	US6329390 5-Bicycloindole compounds
12/11/2001	US6329382 Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine remedies/preventives for respiratory diseases
12/11/2001	US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis
12/11/2001	US6329375 Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
12/11/2001	US6329144 Probe for analysis of target nucleic acids
12/11/2001	US6329116 Cyan coupler and a diazonium salt compound, excellent shelf life, image light-resistance, image fixing, excellent hue and color density, preferably microencapsulated in polyurethane or polyurea
12/11/2001	CA2213108C 2-aminobenzazapine derivatives
12/09/2001	CA2347337A1 Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
12/06/2001	WO2001092280A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
12/06/2001	WO2001092264A1 Adenosine a2a receptor antagonists
12/06/2001	WO2001092263A1 Novel triazolo pyrimidine compounds
12/06/2001	WO2001092262A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/06/2001	WO2001092260A1 4-(2-phenylthiazol-5-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
12/06/2001	WO2001092258A1 Imidazoloisoquinolines
12/06/2001	WO2001092256A1 2,7-naphthyridine derivatives
12/06/2001	WO2001092233A1 3-substituted isoquinolin-1-yl derivatives
12/06/2001	WO2001092229A1 TNF-α PRODUCTION INHIBITORS
12/06/2001	WO2001092200A1 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
12/06/2001	WO2001062760A3 A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
12/06/2001	WO2001040229A3 Method for producing epinastine hydrochloride in the high-melting crystal modification
12/06/2001	WO2001029040A3 PROCESS FOR THE PREPARATION OF PYRIMIDO[5,4-g]PTERIDINE DERIVATIVES
12/06/2001	US20010049439 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
12/06/2001	US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/06/2001	DE10025329A1 New 6-hydroxy-2,3-dihydro-1H-indole derivatives and analogs, useful in cancer therapy, especially used in low toxicity glycoside or acetal prodrug form for antibody directed enzyme prodrug therapy
12/06/2001	CA2746622A1 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
12/06/2001	CA2736344A1 Tnf-.alpha. production inhibitors
12/06/2001	CA2410643A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections
12/06/2001	CA2410640A1 3-substituted isoquinolin-1-yl derivatives
12/06/2001	CA2409617A1 2,7-naphthyridine derivatives
12/05/2001	EP1159964A2 Compositions and methods for stimulating gastrointestinal motility
12/05/2001	EP1159272A1 A process for the preparation of 1,4,7,10-tetraazacyclododecane
12/05/2001	EP0934363B1 Process for colouring high molecular weight organic material and polycyclic pigments
12/05/2001	CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists
12/05/2001	CN1325398A Pyrazolopyrimidinone derivatives for the treatment of impotence
12/05/2001	CN1325377A New esters derived from substituted phenyl-cyclohexyl compounds
12/05/2001	CN1325267A Fused-benzene derivatives useful as herbicides
12/04/2001	US6326383 Emesis therapy
12/04/2001	US6326327 Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use
12/04/2001	CA2237730C Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration
12/04/2001	CA2110260C Pyridonecarboxylic acid derivatives
12/04/2001	CA2042327C Pyrrolo¬2,3-b\|indole-ketones and analogs, a process for their preparation and their use as medicaments
11/2001
11/29/2001	WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001	WO2001090109A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
11/29/2001	WO2001090108A1 3-phenyl-imidazo-pyrimidine derivatives as ligands for gaba receptors
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001003644A9 Pyrazolopyrimidinone derivatives conjugated to thiophene moieties or benzo [fused] 5-membered heterocycles for erectile dysfunction
11/29/2001	US20010047026 Treatment of disorders associated with smooth muscle contraction such as incontinence and irritable bowel syndrome
11/29/2001	US20010046995 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents
11/29/2001	US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
11/29/2001	US20010046983 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
11/29/2001	US20010044974 Oxidation color dyes
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2409644A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/28/2001	EP1157726A1 Reactive crystallization method to improve particle size
11/28/2001	EP1157705A2 Use of a phosphodiesterase inhibitor in the manufacture of a medicament for blood pressure stabilization during hemodialysis
11/28/2001	EP1157026A1 Polycyclo heterocyclic derivatives as antiinflammatory agents
11/28/2001	EP0994878B1 Quinolone carboxylic acid derivatives
11/28/2001	EP0983068B1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324359A Tricyclic carboxamides
11/27/2001	US6324091 Tightly coupled porphyrin macrocycles for molecular memory storage
11/27/2001	US6323344 Hydrolyzing 5-benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxamides compound in presence of strong base to form ketorolac
11/27/2001	US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323213 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/27/2001	US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders.
11/27/2001	US6323201 Compounds for inhibition of ceramide-mediated signal transduction
11/27/2001	US6323197 Non-competitive inhibiting of the ampa receptors, these compounds can be used as medicaments for treatment of the central nervous system
11/27/2001	US6323194 Muscarinic agonists and antagonists
11/27/2001	US6323012 Method for treating viral infections
11/27/2001	US6322908 Organic electroluminescent device
11/26/2001	CA2349136A1 Reactive crystallization method to improve particle size
11/22/2001	WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound
11/22/2001	WO2001087894A1 Antitumoral analogs of et-743
11/22/2001	WO2001087889A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087888A1 Pyrazolopyrimidinone derivatives, process for their preparation and their use
11/22/2001	WO2001087885A1 Crf receptor antagonists
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087853A1 Aryl-substituted n,n-heterocyclic compounds, method for their preparation and their use in therapeutics and diagnostics
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087341A1 Agents for preventing or ameliorating insulin resistance and/or obesity
11/22/2001	WO2001087288A2 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/22/2001	WO2001042246A3 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
11/22/2001	WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
11/22/2001	WO2001029050A3 Condensed pyrrole derivatives as neuraminidase inhibitors
11/22/2001	US20010044539 (2S,3Z)-2-amino-5-(6,7,8,9-tetrahydro-3-oxo-3H,5H -(1,2,4)oxadiazolo(4,3-a)azepin-5-yl)-3-pentenoic acid, for example
11/22/2001	US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine

1 ... 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 ... 573